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INTRODUCTION
Tuberculosis (TB) is a major cause of human mortality and
a worldwide public health problem (1). There are large dis-
crepancies in the rates of TB infection between countries in
each major region and among different locations and demo-
graphic groups within each country. Local and regional in-
creases in the incidence of TB have occurred because of lim-
ited health care resources and societal disruptions (2). 
North Korea’s economic and public health problems began
in the early 1990s as a result of the gradual loss of economic
support from its communist allies, combined with an inor-
dinate number of natural disasters (3, 4). This public health
tragedy has increased the development of active TB in North
Korea; 11,050 cases were reported in 1997 and this increased
to 41,810 in 2003 (184 per 100,000 of the population) (1). 
Dislocated North Koreans have been identified entering
the Republic of Korea since 1954; the number increased from
60 in 1999 to 1,364 in 2005. Such individuals may carry a
significant infectious disease burden as a result of the preva-
lence of disease in their country of origin, exposure during
migration, adverse conditions during migration such as poor
nutrition, and exposure to multiple psychological and phys-
ical stress (5).
Therefore, the goal of this study was to investigate the
prevalence of active TB and latent TB infection (LTBI), mor-
bidity, drug resistance, and Bacille Calmette-Guerin (BCG)
coverage among dislocated North Koreans settled in the
Republic of Korea. Our aim is to initiate a specific control
programme and to plan for the impact of this disease.
MATERIALS AND METHODS
Dislocated North Koreans 
Dislocated North Koreans were defined as refugees from
North Korea, and the study did not include those born to
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Tuberculosis among Dislocated North Koreans Entering Republic of
Korea since 1999
The collapse of North Korea’s public health system has increased the develop-
ment of tuberculosis (TB) in its populace. This study investigated the prevalence of
active and latent TB infection (LTBI) in such people who have settled in the Repub-
lic of Korea since 1999. From 1999 to August 2006, 7,722 dislocated North Kore-
ans entered the Republic of Korea and all were screened immediately for active TB.
Demographic and clinical characteristics were reviewed from the official records of
the Settlement Support Office for Dislocated North Koreans, based in the Ministry
of Unification. Of 7,722 participants, 87 (1.13%) were diagnosed with active TB
from 1999 to August 2006. Of these, 78 (90%) had pulmonary TB. Checking for
the presence of a Bacille Calmette-Guerin (BCG) scar and tuberculin skin test has
been performed in all dislocated North Koreans since November 2005. Of 1,112
participants, BCG vaccination scars were found in 67.4%. The tuberculin-positive
rate using two tuberculin unit doses of the purified protein derivative RT23 (≥ ≥10
mm in diameter) was 81.5%. The prevalence of active TB and LTBI in dislocated
North Koreans was high. Because this group bears a disproportionate burden of
TB, we need to initiate a specific control programme and to plan for the impact of
this disease in the Republic of Korea. 
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refugees outside that country. Since such displaced persons
from North Korea were first identified, the government of
the Republic of Korea has welcomed them officially. To facili-
tate the early settlement of these refugees, the government
of the Republic of Korea established ‘‘Hanawon’’, the Settle-
ment Support Office for Dislocated North Koreans based in
the Ministry of Unification, in 1999. This body provides
board, lodging, education for settlement, and medical care
for three months.
Routine health screening and examination
Health screening is performed for dislocated North Kore-
ans at Incheon Red Cross Hospital, immediately after their
arrival in the Republic of Korea. Screening includes taking a
detailed history of previous diseases and current symptoms,
a physical examination, leukocyte, platelet and differential
leukocyte counts, measurements of hemoglobin and glucose
levels, evaluations of renal and liver functions, serologic testing
for human immunodefficiency virus (HIV), hepatitis, and
syphilis, and a chest radiograph. In addition, each individu-
al completes a questionnaire about any possible risk of expo-
sure to Mycobacterium tuberculosis. For refugees with abnormal
chest radiographs, bacteriological examinations are performed
at the Armed Forces Capital Hospital; these include direct
smears, cultures, drug susceptibility testing, and species iden-
tification. Checking for the presence of a BCG scar has been
done since November 2005. This study was approved by the
ethics review committee and the Institutional Review Board
of the Korean Institute of Tuberculosis (Seoul, Republic of
Korea).
Identification of latent TB infection
The tuberculin skin test (TST) has been performed in all
dislocated North Koreans since November 2005. TST was
done by the Mantoux method, with two tuberculin unit
doses of the purified protein derivative RT23 (Statens Serum
Institute, Copenhagen, Denmark), injected intradermally to
the volar surface of the right forearm. The largest transverse
diameter of palpable induration was measured by a trained
nurse after 48-72 hr.
Identification and examination of active TB 
When dislocated North Koreans have sought medical
advice, the Armed Forces Capital Hospital has given a med-
ical examination and treatment. Using the computerized
database of the Settlement Support Office for Dislocated
North Koreans of the Ministry of Unification and the Armed
Forces Capital Hospital, we identified reported instances of
active TB from January 1999 to August 2006. We reviewed
baseline demographic and clinical information, including
age, sex, previous treatment for active TB or contact history,
laboratory reports of bacteriological studies, and radiological
reports. If patients’ sputa showed acid-fast bacilli, mycobac-
terial culture with species identification was performed by
the Korean Institute of Tuberculosis. We examined the drug
susceptibility testing (DST) results of initial cultures against
the first-line anti-tuberculosis medications: isoniazid (INH),
rifampicin, ethambutol, pyrazinamide, and streptomycin.
Statistical analysis
To compare the prevalence of active and LTBI of the dislocat-
ed North Korean subjects with those of civilians of the Repub-
lic of Korea, we calculated the prevalence ratio (PR) adjusted
by age and sex as follows: PR=(observed number of TB cases
in dislocated North Koreans)/(expected number of TB cases
in South Koreans). The expected number of TB cases in the
Republic of Korea was taken from the data of the nationwide
TB prevalence surveys in the country in 1995 (6) after being
adjusted for age and sex. Student’s t-test was performed for
continuous variables and Pearsons chi-square test or Fisher’s
exact test (if the expected number was less than five in at least
one cell) were used for categorical variables. p<0.05 was regard-
ed as statistically significant. Analyses were performed using
SPSS software, version 11.0 (SPSS Inc, Chicago, IL, U.S.A.).
RESULTS
Characteristics of dislocated North Koreans
Since 1954, 8,313 North Koreans have entered the Republic
of Korea; 7,722 entered between 1999 and August 2006 and
were eligible in this study. Of these, 2,828 (36.6%) were
men and 4,894 (63.4%) were women, with a median age of
32 yr (range, 0-85). The median duration of migration out-
side of both Koreas was 27 months (range 0-205). The mean
body mass index was 21.2±2.76 kg/m2 in men and 21.7±
2.81 kg/m2 (p<0.001) in women. No subject was HIV sero-
positive. The countries the dislocated North Koreans arriv-
ed from were China (30.4%), Mongolia (22.4%), Cambodia
(18.7%), Thailand (11.9%), and others (16.6%). The areas
where persons originally lived in North Korea were North
Hamgyong (70.2%), South Hamgyong (11.3%), South Pyon-
gan (3.4%), Ryanggang (3.2%), North Pyongan (3.0%), and
others (8.9%).
Cases of active TB
Eighty-seven individuals with active TB were identified
from 1999 to August 2006. Of these, 78 (90%) had pul-
monary TB, three (3%) had TB pleurisy, four (5%) had TB
lymphadenitis, one (1%) had TB meningitis, and one (1%)
had TB spondylitis. In 27 individuals (31%), the diagnosis of
active TB was confirmed bacteriologically. Thus, the preva-TB in North Korean Refugees 965
lence of active TB was 1,127/100,000 and that of smear-
and/or culture-positive TB was 350/100,000 (Table 1). The
prevalence of active TB was higher in men than in women
(1,733/100,000 vs. 776/100,000, p<0.001). The prevalence
of selected age-specific active TB cases is shown in Table 2;
44 (51%) individuals had a history of previous active TB.
Thirteen (14.9%) active TB cases were diagnosed at pre-de-
parture screening before final entry into the Republic of Korea.
BCG vaccination scar and latent TB infection  
After November 2005, 1,112 subjects were screened for
their possible exposure to M. tuberculosis as shown by a TST.
The survey of presence of BCG vaccination scars were also
performed. Of these, 65 (5.8%) subjects had a history of
previous active TB and 120 (10.8%) had a history of contacts
with patients with active TB. BCG vaccination scars were
found in 67.4%. A comparison of TST reactivity with the
presence of BCG vaccination scars and cut-off values in the
dislocated North Koreans are shown in Table 2 and Fig. 1.
BCG vaccination scars were significantly less frequent in those
aged under 30 yr than in those older (56.6% vs. 76.0%; p<
0.001).
The tuberculin positive reaction (≥10 mm in diameter)
rate was 81.5%. The positive rate of this TST was higher
among participants with BCG scars than among participants
without BCG scars (85.8% vs. 72.5%; odds ratio 2.31; 95%
CI, 1.70-3.14). We performed an analysis of risk factors for
a positive TST. The following factors were associated with a
positive TST: a previous history of active TB, odds ratio 3.65
1999 2000 2001 2002 2003 2004 2005 2006* Total
Total 60 297 572 1,111 1,175 1,935 1,364 1,208 7,722
No. TB cases -- 8 8 11 28 17 15 87
Prevalence
� -- 1,399 720 936 1,447 1,246 1,242 1,127 
No. smear and/or culture+ --2 (25.0) 5 (62.5) 5 (45.5) 6 (21.4) 5 (29.4) 4 (26.7) 27 (31.0)
Prevalence
� -- 350 450 426 310 367 331 350
Sex
Male --6 (75.0) 5 (62.5) 7 (63.6) 16 (57.1) 8 (47.1) 7 (46.7) 49 (56.3)
Female --2 (25.0) 3 (37.5) 4 (36.4) 12 (42.9) 9 (52.9) 8 (53.3) 38 (43.7)
Age yr, median (range) -- 38 (28-66) 35 (6-63) 34 (26-58) 35 (15-46) 28 (16-53) 32 (12-45) 35 (6-66)
Site of TB
Pulmonary --7 (87.5) 7 (87.5) 11 (100) 24 (85.7) 15 (88.2) 14 (93.3) 78 (89.7)
Extrapulmonary --1 (12.5) 1 (12.5) - 4 (14.3) 2 (11.8) 1 (6.7) 9 (10.3)
History of previous TB --3 (37.5) 6 (75.0) 4 (36.4) 14 (50.0) 9 (52.9) 8 (53.3) 44 (50.6)
Duration of chemotherapy --3 (0-3) 6 (1-9) 2 (0-5) 2 (0-18) 3 (1-8) 1.5 (0-18) 2 (0-18)
Duration of migration -- 32 (2-51) 16 (5-54) 45 (0-67) 15 (3-92) 20 (1-75) 18 (0-93) 21 (0-93)
Table 1. The prevalence of active TB infection and demographic features among the dislocated North Koreans
Data are presented as number (%), median (range).
*From January until August 2006; 
� per 100,000 population. TB, Tuberculosis; +, positive.
0-4 5-14 15-24 25-34 35-44 45-54 55-64 ≥65 Total
No. of dislocated North Koreans 77 521 1397 2488 2007 633 325 274 7,722
Prevalence
Active TB* - 576 859 1,125 1,495 1,738 615 365 1,127
Smear and/or culture+TB* --143 402 498 474 615 0 350
No. of tested by TST 12 62 195 419 291 76 39 18 1,112
Sex
Male 10 29 60 46 58 15 9 4 231
Female 2 33 135 373 233 61 30 14 881
Positive (cutoff 10 mm)
With BCG scar 1 (33.3) 8 (66.7) 79 (74.5) 264 (86.6) 235 (91.1) 42 (89.4) 10 (79.6) 4 (80.0) 643 (85.8)
Without BCG scar 1 (11.1) 21 (42.0) 61 (68.5) 93 (81.6) 29 (87.9) 28 (96.6) 21 (80.8) 9 (69.2) 263 (72.5)
Positive (cutoff 5 mm)
With BCG scar 1 (33.3) 8 (66.7) 94 (88.7) 290 (95.1) 250 (96.9) 47 (100) 12 (92.3) 4 (80.0) 706 (94.3)
Without BCG scar 1 (11.1) 25 (50.0) 67 (75.3) 103 (90.4) 32 (97.0) 29 (100) 24 (92.3) 13 (100) 294 (81.0)
No. with BCG scar 3 (25.0) 12 (19.4) 106 (54.4) 305 (72.8) 258 (88.7) 47 (61.8) 13 (33.3) 5 (27.8) 749 (67.4)
Table 2. Epidemiologic data of TB by age group among the dislocated North Koreans
Data are presented as number (%).
*per 100,000 population. TB, Tuberculosis; +, positive; TST, tuberculin skin tests; BCG, Bacille Calmette-Guerin.966 C.-M. Choi, J.-H. June, C.-I. Kang, et al.
(95% CI 1.31-10.14); contacts with active TB patients, 1.99
(95% CI 1.10-3.61); and the presence of a BCG scar, 2.31
(95% CI, 1.70-3.14). The annual risk of LTBI in the 5-14
yr-old age group without BCG scars (n=50) was 4.6% (mean
duration of migration 16 months; mean age 11.1 yr).
Drug resistance
Of 78 active TB patients, there were 22 (40%) culture-
positive patients. Of the 22 M. tuberculosis isolates obtained
from the patients’ respiratory specimens, 13 underwent DST.
Of these, four (31%) isolates were susceptible to all available
anti-tuberculosis drugs. The remaining nine isolates (69%)
were resistant to at least one drug in vitro. Among these, six
(67%) were resistant only to INH, and three (33%) were
multi-drug resistant (MDR); one of these was a primary
MDR form of TB and two were acquired MDR forms.
Comparison with statistics of the Republic of Korea
The reported rates of active TB among civilians in the
Republic of Korea were 1,842/100,000 in 1990 and 1,032/
100,000 in 1995 (6). The PR of active pulmonary TB was
1.29 (95% CI, 1.02-1.61), and the smear- and/or culture-
positive PR was 2.03 (95% CI, 1.34-2.95). Among the dis-
located North Koreans younger than 30 yr, 56.6% had
BCG scars. In the Republic of Korea, 91.8% of individuals
had BCG scars in 1995 (6). The LTBI rate of the North Kore-
an refugees younger than 30 yr without BCG scars was 62.3
%. In the Republic of Korea, this was 15.5% in 1995 (6).
The PR of LTBI was 1.35 (95% CI, 1.12-1.60). The annual
risk of LTBI in refugees aged 5-14 yr without BCG scars
(n=50) was higher than among civilians of the Republic of
Korea (4.6% vs. 0.5%) (6).
DISCUSSION
Since being liberated from Japanese rule in 1945, the Repub-
lic of Korea has achieved remarkable economic growth under
democracy and a market economy. On the other hand, North
Korea has maintained a socialist system and has suffered from
economic crisis since the 1990s. Economic status not only
directly influences the health level, but also indirectly affects
it through influences on nutrition, hygiene, health resources,
and other intervening factors (4, 7). During the peak years
for public health in North Korea in 1980, the North Kore-
an government claimed that active TB had been ‘‘eradicated’’
in the country (1, 3). However, since the public health crisis
in North Korea after 1995, there has been a marked increase
in the incidence of smear- and/or culture-positive TB. The
abrupt decline in the presence rate of BCG vaccination scar
among refugees younger than 30 yr in our study (56.6%)
presumably reflects this decay in the North Korean health
system. In North Korea, 11,050 cases of active TB were
notified in 1997 and this increased to 41,810 in 2003 (184
cases per 100,000 population) (1). This was higher than in
the Republic of Korea during the same period (33,888; 71
cases per 100,000 population) (1). Today, TB remains one of the
most serious public health problems in North Korea.
By contrast, the government of the Republic of Korea has
concentrated its limited resources for public health activities
on TB control programmes, whereas the private sector has
taken charge of constructing the health delivery system, includ-
ing health facilities and human resources. The Republic of
Korea has performed nationwide active TB prevalence surveys
at five-yearly intervals from 1965 to 1995, and the results of
the last (the seventh) survey have been reported (6). Over the
past 30 yr the prevalence of direct smear-positive individu-
als has reduced from 683 to 93 per 100,000; that of smear-
and/or culture-positive individuals has reduced from 940 to
219 per 100,000 and the prevalence of active TB has gone
down from 5,065 to 1,032 per 100,000. 
Since 1954, 8,313 North Korean refugees have entered
Republic of Korea; 7,722 have entered since 1999 because
of the economic crisis. Dislocated North Koreans may carry
active TB and LTBI as a result of economic and cultural
changes and psychological and environmental stresses (8).
In this study, the prevalence of active TB was 1,127 per
100,000 in dislocated North Koreans, which is higher than
that of the Republic of Korea in 1995 (1,032 per 100,000; PR
1.29; 95% CI 1.02-1.61). When persons migrate from such
nations with poor health care, they often carry LTBI that
may reactivate after arrival in the host country. The preva-
lence of LTBI among dislocated North Koreans aged under
30 years without a BCG scar was 62.3%, much higher than
that of the Republic of Korea; 15.5% in 1995 (PR, 1.35; 95%
CI 1.12-1.60). Because of the remarkable decline in the inci-
dence of active TB in the Republic of Korea after 1995, the
overall PR has been higher recently. Therefore, interventions
Fig. 1. Comparison of tuberculin skin test reactivity with the pres-
ence of BCG vaccination scars among the dislocated North Kore-
ans.
%
100.0
80.0
60.0
40.0
20.0
0.0
0-4 5-14 15-24 25-34 35-44 45-54 55-64 ≥65
Age (yr)
Total
BCG scar (+)
BCG scar (-)that target recent dislocated North Koreans can contribute
both to the health of those individuals and to overall TB
control in the Republic of Korea. The risk of progression to
active TB is greatest soon after arrival; approximately half
the active TB cases among immigrants from endemic coun-
tries occur during the first five years after immigration (9).
Among these dislocated North Koreans, 38 newly active
TB cases were diagnosed during the first years after entry
into the Republic of Korea, and specialized re-screening pro-
grammes for dislocated North Koreans are required. 
Outbreaks due to multi-drug-resistant TB (MDR-TB)
have occurred in a number of locations, often associated with
breakdowns in health care infrastructures. Because of the
higher rate of previous treatments for active TB, immigra-
tion has been suggested as one factor leading to the increased
prevalence of MDR-TB (10). In our study, although DST
was performed for only 13 isolates, 69% of these were resis-
tant to at least one drug in vitro and 23% were MDR; higher
than those of the Republic of Korea (12.3% and 2.4%, respec-
tively) (11). Rates of drug resistance among immigrant pop-
ulations reflect the rates in the countries of origin, which are
significantly higher in many developing countries than in
developed countries (12). Incomplete and inadequate treat-
ment is the most important factor leading to its develop-
ment, suggesting that it is often a man-made tragedy (13).
The high prevalence of MDR-TB among dislocated North
Koreans thus reflects the poor infrastructure of the health
care system of North Korea. 
TB has always been associated with social stigma. Because
refugees from North Korea are also at risk of discrimination,
the stigma attached to active TB may raise formidable bar-
riers to effective healthcare. Dislocated North Koreans may
avoid seeking care for active TB, because of a fear that they
will experience discrimination or isolation if they are associ-
ated with this contagious illness. The responses of medical
providers, whether leaning toward xenophobia or compas-
sion, will have major impacts on societal responses to dislo-
cated North Koreans with active TB. The increased case of
international travel has led to increasing recognition that
infectious diseases have no borders (8).
This is the first report on the extent of active TB and LTBI
in dislocated North Koreans settled in the Republic of Korea.
However, there are limitations in our findings. Fewer than
40% of active TB cases were confirmed microbiologically, and
few had DST results. The fact that anti-TB medication was
initiated after pre-departure screening for active TB among
13 (15%) of the dislocated North Koreans with active TB
might explain the lower rate of bacteriologic confirmation
of the disease. 
In conclusion, our results have documented the prevalence of
active and LTBI among dislocated North Koreans. These peo-
ple bear a disproportionate burden of infectious disease be-
cause of the circumstances under which they have migrated
to the Republic of Korea. We need to initiate a specific con-
trol programme and to plan for the impact and control of TB
in the Republic of Korea. In parallel with our efforts to improve
the living standards of North Koreans and our consistent pur-
suit of a policy of reconciliation and cooperation towards the
North, we are also trying to reduce or eliminate the causes for
their exodus.
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